Thursday, March 3, 2022

< + > WHO Backs Merck’s Antiviral Pill For High-Risk Covid Patients But Finds Regeneron’s Antibody Cocktail ‘Ineffective’ Against Omicron

The WHO panel is also evaluating data for Pfizer’s antiviral pill, paxlovid, and a widely available antidepressant, fluvoxamine, to treat Covid-19.

at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

< + > Weekly Roundup – August 22, 2026

Welcome to our Healthcare IT Today Weekly Roundup . Each week, we’ll be providing a look back at the articles we posted and why they’re impo...